The Filing Desk

OmniAb vs Seer

OmniAb OABI · Seer SEER · Life Sciences Tools & Services

OmniAb reported revenue of $19 million in fiscal 2025, about the same as Seer's $17 million in fiscal 2025. OmniAb's revenue fell 29.3% in its latest year, and Seer's grew 17.0%. OmniAb had an operating margin of -369.5%, against -470.4% at Seer. Free cash flow was −$37 million at OmniAb and −$46 million at Seer.

Side by side

OmniAbSeer
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$19M$17M
Revenue growth−29.3%17.0%
Revenue growth a year, last 5 years—88.4%
Gross margin—51.1%
Operating margin−369.5%−470.4%
Net margin−347.0%−444.0%
Free cash flow−$37M−$46M
Free cash flow margin−198.3%−278.9%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count11.0%—
Last close$5.03$1.39
P/E at the last close——
Insider trades, last 12 monthssold $283,037sold $117,931
Piotroski F-score——
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
OmniAbSeer
Operating margin
Percent of revenue
OmniAbSeer
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
OmniAbSeer

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the OmniAb and Seer pages.